1–4 of 4 results for age-related macular degeneration non-neovascular
Learnings From the Lampalizumab Chroma and Spectri Phase 3 Trials: Effect of Baseline Characteristics on Geographic Atrophy Progression
Carl D. Regillo, MD
Annual Meeting Talks
2018
Common Age-Related Macular Degeneration Genetic Risk Variants and Geographic Atrophy Lesion Growth in the Chroma and Spectri Phase 3 Lampalizumab Trials
Karl G. Csaky, MD, PhD
Direct-to-Consumer Marketing by U.S. Cell Therapy Clinics for Retinal Conditions
Ajay E Kuriyan, MD, MS
Progression of Visual Function Endpoints in Early and Intermediate Age-Related Macular Degeneration
Eleonora Lad, MD, PhD